1. Home
  2. AAUC vs AMRX Comparison

AAUC vs AMRX Comparison

Compare AAUC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AAUC

Allied Gold Corporation

HOLD

Current Price

$31.85

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$13.10

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAUC
AMRX
Founded
N/A
2002
Country
Canada
United States
Employees
2252
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
AAUC
AMRX
Price
$31.85
$13.10
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$14.75
AVG Volume (30 Days)
257.3K
1.3M
Earning Date
03-31-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.22
Revenue
N/A
N/A
Revenue This Year
$63.46
$4.48
Revenue Next Year
$25.91
$7.13
P/E Ratio
N/A
$59.30
Revenue Growth
N/A
N/A
52 Week Low
$11.40
$7.02
52 Week High
$32.08
$15.42

Technical Indicators

Market Signals
Indicator
AAUC
AMRX
Relative Strength Index (RSI) 66.91 55.99
Support Level $30.99 $12.50
Resistance Level $32.08 $13.54
Average True Range (ATR) 0.24 0.34
MACD 0.05 0.14
Stochastic Oscillator 86.09 87.78

Price Performance

Historical Comparison
AAUC
AMRX

About AAUC Allied Gold Corporation

Allied Gold Corp is a company focused on gold mining activities in Africa. Allied has three mines and several development and exploration projects in Africa where it has operating experience. Operations are located in Cote d'Ivoire, Mali, and Ethiopia. The company expands and optimizes initiatives at existing operating mines, the development of new mines, the advancement of its exploration properties, and, targeting other consolidation opportunities with a focus on Africa.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: